FDA Approves New Drug for Wilson ' s Disease FDA Approves New Drug for Wilson ' s Disease

Trientine tetrahydrochloride (Cuvrior) is approved to treat adults with stable Wilson ' s disease who are decoppered and tolerant to penicillamine.FDA Approvals
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news